John James, MD
Family Medicine · Alexander City, ALNPI 1811907579
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $345 and has fallen 87.5% since, to $43 in 2025.
Across 84 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$186
- Johnson & Johnson$180
- AbbVie$159
- Exact Sciences$145
- Amgen$145
- Lilly USA, LLC$109
- plus $615 from 13 others
What the payments were for
- Food & beverage$1,45895%
- Education$805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $186 |
| Johnson & Johnson | 10 | $180 |
| AbbVie | 7 | $159 |
| Exact Sciences | 7 | $145 |
| Amgen | 8 | $145 |
| Lilly USA, LLC | 7 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $100 |
| GSK | 5 | $81 |
| Astellas Pharma US Inc | 1 | $80 |
| Pfizer | 4 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Novo Nordisk | 3 | $49 |
| Novartis | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Bayer | 1 | $27 |
| Dexcom, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $9 |
How this compares
$1,538 in reported general payments places this provider in the 65th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 79 | $85,107 |
| EliquisApixaban | 85 | $70,140 |
| JardianceEmpagliflozin | 34 | $28,995 |
| JanuviaSitagliptin Phosphate | 33 | $24,090 |
| LinzessLinaclotide | 31 | $23,851 |
| FarxigaDapagliflozin Propanediol | 23 | $23,361 |
| TrulicityDulaglutide | 20 | $20,787 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $19,513 |
| MounjaroTirzepatide | 15 | $18,321 |
| MyrbetriqMirabegron | 13 | $10,731 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,653 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 70 | $8,872 |
| Gabapentin | 306 | $6,137 |
| Levemir FlexpenInsulin Detemir | 22 | $5,764 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 434 | $5,708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $49 | $85,10779 claims |
| PfizerEliquis | $74 | $70,14085 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $109 | $39,10835 claims |
| Boehringer IngelheimJardiance | $15 | $28,99534 claims |
| AbbVieLinzess, Synthroid | $159 | $25,62963 claims |
| AstraZenecaFarxiga | $186 | $23,36123 claims |
| GSKTrelegy Ellipta | $81 | $19,51324 claims |
| Astellas Pharma US IncMyrbetriq | $80 | $10,73113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Alexander City
- Lashelle BarmoreBirmingham$486K
- Regina BenjaminBayou la Batre$222K
- Jonathan ParkerMuscle Shoals$214K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Kelly HunterTuscaloosa$84K
- Daniel EnglertHuntsville$82K
- Joel LaughlinMobile$75K
- Ashleigh Butts-WilkersonMobile$54K
- Philip WilsonDothan$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.